High materiality8/10
RBC Capital Upgrades ResMed (RMD) to Outperform
Why it may matterVerify against the original reporting
Buy
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
RBC Capital upgrades ResMed (RMD) to Outperform; target price $262; current price $222.99.
- RBC Capital upgrades RMD to Outperform; target $262; price $222.99.
- Upgrade implies upside potential for RMD.
Key facts
- 01
Target: $262
- 02
Posted price: $222.99
- 03
Analyst firm: RBC Capital
- 04
Analyst: Craig Wong-Pan
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.